Article Details

Q2 2022 EPS Estimates for CytomX Therapeutics, Inc. (NASDAQ:CTMX) Lifted by Wedbush

Retrieved on: 2022-05-13 13:01:19

Tags for this article:

Click the tags to see associated articles and topics

Q2 2022 EPS Estimates for CytomX Therapeutics, Inc. (NASDAQ:CTMX) Lifted by Wedbush. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 4,992,094 shares of the biotechnology company's stock valued at $13,328,000 after buying an additional 29,732 shares during ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up